π 50 Stocks With Strong Q1 FY27 Concall Commentary ππ₯
πΉ #SGMART β π 118% EBITDA growth outlook; βΉ300 Cr EBITDA target for FY27
πΉ #SENORES β π Targeting 30β40% revenue growth and 50β60% PAT growth in FY27
πΉ #SAKAR β 𧬠25% revenue CAGR with 50%+ PAT growth; oncology business ramp-up is a key catalyst
πΉ #SGFIN β π° Targeting 43% PAT growth and βΉ225 Cr PAT in FY27
πΉ #SHADOWFAX β π FY27 revenue growth guidance upgraded sharply to 38β40%
πΉ #NEOGEN β π ~40% revenue growth expected, supported by battery-chemical expansion
πΉ #HFCL β π FY27 revenue growth guidance doubled to 40% from 20%
πΉ #SAHASRA β β‘ Targeting 100% revenue growth and βΉ275β300 Cr revenue in FY27
πΉ #SANGAMIND β π Management targeting 100% PAT growth in FY27
πΉ #JSFB β π¦ 80%+ PAT growth outlook, with strong loan and deposit growth targets
πΉ #MOTILALOFS β π Housing finance AUM expected to grow 20%+ annually over the next 2β3 years
πΉ #BORORENEW β βοΈ Targeting 60% revenue & EBITDA growth; 600 TPD capacity expansion planned
πΉ #MBAPL β πΎ >50% revenue growth expected in FY27, led by the Dhule SSP ramp-up
πΉ #ATLANTAELE β β‘ Management sees ~40% revenue CAGR over the next 3 years
πΉ #NETWEB β π₯οΈ 35β40% revenue growth outlook with healthy margin expectations
πΉ #SYRMA β π 30β35%+ growth opportunity with strong FY27 targets
πΉ #JUBLINGREA β π§ͺ 32β40% EBITDA growth target; βΉ750β800 Cr EBITDA outlook
πΉ #KRISHANA β π± 30β35% revenue growth guidance for FY27
πΉ #ARSSBL β π 30β35% PAT growth expected in FY27
πΉ #CGCL β π° 30%+ AUM CAGR targeted through FY28
πΉ #SOBHA β ποΈ 30%+ pre-sales growth target for FY27

















